EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 339 filers reported holding EXELIXIS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,181,000 | -5.8% | 150,480 | -12.4% | 0.01% | -57.6% |
| Q4 2018 | $3,378,000 | -49.3% | 171,731 | -54.3% | 0.03% | +43.5% |
| Q3 2018 | $6,660,000 | -72.1% | 375,786 | -66.1% | 0.02% | -83.0% |
| Q2 2018 | $23,870,000 | -40.1% | 1,109,202 | -38.4% | 0.14% | -32.5% |
| Q1 2018 | $39,877,000 | +2.5% | 1,800,332 | +40.6% | 0.20% | -7.0% |
| Q4 2017 | $38,918,000 | +74.9% | 1,280,189 | +38.1% | 0.22% | +52.5% |
| Q3 2017 | $22,249,000 | -27.7% | 927,039 | -24.6% | 0.14% | -37.3% |
| Q2 2017 | $30,755,000 | +81.2% | 1,230,182 | +59.4% | 0.22% | +67.9% |
| Q1 2017 | $16,976,000 | – | 771,655 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
| NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
| GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
| Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
| Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
| Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
| BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
| CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
| TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |